Company Name: Formation Biologics Inc.
Head Office: Montreal, Quebec, Canada
Number of Employees: 1 to 49
Total Assets: Under $5 million

August 16, 2019 – Formation Biologics Inc. sold 1,025 convertible Class C Preference Shares at a price of $90 per share for $92,250.

Each Preference Shares has a conversion ratio of 1:1 to Common.

The securities were sold to 2 accredited investors in Switzerland.

Formation Biologics Inc. is a clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. Forbius was founded in 2011 as a management-led spin out from YM BioSciences, prior to YM’s acquisition by Gilead.

****

Company Name: Oryx Petroleum Corporation Ltd.
Head Office: Calgary, Alberta, Canada
Number of Employees: 100 to 499
Total Assets: $500 million to $1 billion

August 19, 2019 – Oryx Petroleum sold 23,901,430 Common Shares at a price of $0.2789 per unit for $6,666,109.

The securities were sold to 1 accredited investor in Netherlands.

Oryx Petroleum is an international oil exploration, development and production company focused in Africa and the Middle East.

About Canadian Investor News

This author writes about mergers & acquisitions and investments in Canadian businesses. For investors in Canada.